Old Web
English
Sign In
Acemap
>
authorDetail
>
Kenna A. Landon
Kenna A. Landon
Cancer research
Biology
Mechanistic target of rapamycin
PI3K/AKT/mTOR pathway
Protein kinase B
5
Papers
128
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The protein arginine methyltransferase PRMT5 confers therapeutic resistance to mTOR inhibition in glioblastoma.
2019
Journal of Neuro-oncology
Brent Holmes
Angelica Benavides-Serrato
Jacquelyn T. Saunders
Kenna A. Landon
Adam J. Schreck
Robert N. Nishimura
Joseph Gera
Show All
Source
Cite
Save
Citations (20)
mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma
2018
Oncogene
Brent Holmes
Angelica Benavides-Serrato
Ryan S. Freeman
Kenna A. Landon
Tariq Bashir
Robert N. Nishimura
Joseph Gera
Show All
Source
Cite
Save
Citations (26)
Correction: Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma
2017
PLOS ONE
Angelica Benavides-Serrato
Jihye Lee
Brent Holmes
Kenna A. Landon
Tariq Bashir
Michael E. Jung
Alan Lichtenstein
Joseph Gera
Show All
Source
Cite
Save
Citations (48)
1